Skip to main content
. Author manuscript; available in PMC: 2013 Apr 29.
Published in final edited form as: Am J Gastroenterol. 2008 Oct 3;103(12):3029–3035. doi: 10.1111/j.1572-0241.2008.02188.x

Table 2.

Correlations between Measures of Hepatic Steatosis (L:SAR and Liver Attenuation) and Regional Body Fat

Model Number Spearman r GEE-adjusted P Value
BMI to L:SAR 0 623 −0.2296 <0.0001
BMI to L:SAR 1 623 −0.1931 <0.0001
BMI to liver attenuation 0 623 −0.3137 <0.0001
BMI to liver attenuation 1 623 −0.2813 <0.0001
Subcutaneous fat at L4/L5 to L:SAR 0 596 −0.1267 0.0002
Subcutaneous fat at L4/L5 to L:SAR 1 596 −0.1332 0.0031
Subcutaneous fat at L4/L5 to liver attenuation 0 596 −0.2181 <0.0001
Subcutaneous fat at L4/L5 to liver attenuation 1 596 −0.2109 0.0005
Intra-abdominal fat at L4/L5 to L:SAR 0 598 −0.3166 <0.0001
Intra-abdominal fat at L4/L5 to L:SAR 2* 598 −0.2236 <0.0001
Intra-abdominal fat at L4/L5 to liver attentuation 0 598 −0.3598 <0.0001
Intra-abdominal fat at L4/L5 to liver attentuation 2* 598 −0.2335 <0.0001

Model 0: Unadjusted.

Model 1: Adjusted for age, gender, race, diabetes status, pack-years smoking history, and intra-abdominal fat.

Model 2: Adjusted for age, gender, race, diabetes status, and pack-years smoking history.

*

Model 2 was used here because intra-abdominal fat cannot be adjusted for itself and yield a meaningful result.